D-0870-2023 Class III Terminated
FDA drug recall D-0870-2023 was initiated by HF Acquisition Co LLC on Jun 6, 2023 and is designated Class III. Reason for recall: Labeling: Label Mix-up The recall status is terminated (terminated Feb 27, 2024). Affected quantity: 9 boxes of 25 vials.
Recall Details
- Product Type
- Drugs
- Report Date
- Jun 14, 2023
- Initiation Date
- Jun 6, 2023
- Termination Date
- Feb 27, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 9 boxes of 25 vials
Product Description
GLYCOPYRROLATE INJECTION, USP 0.2MG/ML, 1mL VIAL, manufactured by HF Acquisition Co. LLC, Mukilteo, WA 98275, NDC 51662-1487-3
Reason for Recall
Labeling: Label Mix-up
Distribution Pattern
Distributed in TX, AZ and CA only
Code Information
Lot #: 2205095.1, Exp. Date 7/31/2024
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0870-2023
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026